The common disease course of psoriatic arthritis begins with the formation of characteristic skin lesions. The joint symptoms of psoriatic arthritis can follow sometimes as many as 10 years later. Like psoriasis, the condition can flare and subside. In up to 20 percent of patients, the signs and symptoms of psoriatic arthritis, including painful swelling of the joints, hands, feet and connective tissue, will appear first. About one-third of people with psoriatic arthritis will develop a destructive form of the disease, which includes progressive joint damage that eventually can make movement painfully difficult.
Like psoriasis, psoriatic arthritis can begin at any time; it usually strikes adults between ages of 30 and 50. Children can develop a form of the disease called juvenile psoriatic arthritis. Men and women are generally affected equally, though the disease may be slightly more common in women. It is found in all ethnic groups, but some studies suggest a higher prevalence among Caucasians.
Despite the prevalence of both psoriasis and psoriatic arthritis, the potential severity of both conditions is often overlooked, and both diseases are commonly misunderstood even by the people who experience them. According to a survey conducted by the National Psoriasis Foundation, one-third of the people who suffer from psoriasis said they also experience persistent joint stiffness or stiffness for at least 3 months, but they were not diagnosed with psoriatic arthritis. This fact leads researchers to believe that the condition is going untreated or unrecognized.
Learning to identify the signs and symptoms of psoriatic arthritis is important, because when left untreated, the disease can diminish quality of life and lead to painful, irreversible joint damage. Fortunately, efforts are underway to increase patient and physician awareness about the chronic condition. While there is no cure for psoriasis or psoriatic arthritis, there are safe and effective treatments that, when used at the first sign of disease, can help people manage these potentially disabling diseases. Researchers are spending more time looking into more effective and safer treatment methods that will isolate and control the bodily mechanisms believed to trigger these conditions.